ID   MVA-RCC-A6H
AC   CVCL_C4Z2
SY   A6H
DR   Wikidata; Q116049834
RX   Patent=EP0210970A2;
RX   PubMed=3904980;
RX   PubMed=11604108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8803.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   Patent=EP0210970A2;
RA   Vessella R.L., Lange P.H.;
RT   "Detection, imaging and therapy of renal cell carcinoma with
RT   monoclonal antibodies.";
RL   Patent number EP0210970A2, 13-Jan-1988.
//
RX   PubMed=3904980;
RA   Vessella R.L., Moon T.D., Chiou R.-K., Nowak J.A., Arfman E.W.,
RA   Palme D.F., Peterson G.A., Lange P.H.;
RT   "Monoclonal antibodies to human renal cell carcinoma: recognition of
RT   shared and restricted tissue antigens.";
RL   Cancer Res. 45:6131-6139(1985).
//
RX   PubMed=11604108; DOI=10.1089/027245701753179802;
RA   Hass G.M., Meyer J.L., Newitt R.A., Labuda T., Brown L., Aebersold R.,
RA   Vessella R.L.;
RT   "Identification of the target of monoclonal antibody A6H as dipeptidyl
RT   peptidase IV/CD26 by LC MS\MS.";
RL   Hybridoma 20:231-236(2001).
//